tetramethylpyrazine has been researched along with Bright Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, H; Tang, R; Tong, J; Wang, Y; Xu, J | 1 |
| Huang, Q; Li, B; Wei, M; Xu, W; Zhu, L | 1 |
| Lu, C; Sun, L; Ye, R | 1 |
1 trial(s) available for tetramethylpyrazine and Bright Disease
| Article | Year |
|---|---|
[Influence of ligustrazine-contained peritoneal dialysate on efficiency of dialysis].
Topics: Adult; Female; Glomerulonephritis; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Pyrazines; Ultrafiltration | 1998 |
2 other study(ies) available for tetramethylpyrazine and Bright Disease
| Article | Year |
|---|---|
Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Female; Fluorescent Antibody Technique, Direct; Glomerular Basement Membrane; Glomerulonephritis; Immunoglobulin G; Kidney Glomerulus; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Proteinuria; Pyrazines; Rats; RNA, Messenger; Thromboxane A2 | 2004 |
Study on the therapeutic effects of traditional Chinese drugs in experimental glomerulonephritis.
Topics: Animals; Drugs, Chinese Herbal; Fibrinolytic Agents; Glomerulonephritis; Male; Pyrazines; Rabbits; Serum Albumin, Bovine | 1993 |